
|Videos|August 17, 2015
Need-to-Knows about Dual Add-On Therapy to Insulin
Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville talks about need-to-knows for dual add on therapy to insulin.
Advertisement
Jessica Kerr, PharmD, CDE, and assistant department chair at Southern Illinois University Edwardsville talks about need-to-knows for dual add on therapy to insulin.
This video was filmed at CHPC 2015.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updates in Treatment of Unresectable Hepatocellular Carcinoma
2
Soaring off the Patent Cliff: Preparing for the Next Wave of Oncology Biosimilars
3
FDA Approves Depemokimab as Add-On Maintenance Treatment in Severe Asthma
4
Infliximab and Adalimumab Biosimilars Maintain Comparable Safety, Efficacy, Immunogenicity in IBD
5











































































































































































































